CD8A and leukemia: To arrive at the T cell score, vaccination-induced T cell immune responses were scored in four different categories, i.e., (1) T cell proliferative response to the DCP-001, (2) a positive post-vaccination leukemia-associated antigen-specific ELISpot reactivity, (3) increased number of infiltrating CD4+ or CD8+ T cells in the superficial dermis of the post-vaccination DTH site (by immunohistochemistry, see Supplementary Fig. 3b and 4) post-vaccination increase in DTH site induration.